The CBD Oil Market is projected to reach USD 264.74 billion by 2033, growing from USD 19.41 billion in 2023 at a compound annual growth rate (CAGR) of 38.74% from 2023 to 2033. This market encompasses the global industry involved in the production, distribution, and sale of cannabidiol (CBD) oil, which is derived from the cannabis plant. Known for its potential therapeutic benefits, CBD oil is used for pain relief, reducing anxiety and depression, and alleviating cancer-related symptoms, among other uses. The market includes various CBD oil products such as tinctures, capsules, topicals, and edibles.
The latest research report by Evolve Business Intelligence explores the various factors influencing the global market. It includes an analysis of the current market size, forecasts for key segments and regions, and the driving forces behind market growth. The report examines the potential impacts of key trends on business strategies and provides a SWOT analysis of critical sectors for each major competitor and customer group. This valuable data highlights the conglomerates likely to impact the industry, crucial for any company planning to invest strategically over the next five years. These insights complement our initial quantitative study, aiding in new investments and strategic planning to mitigate threats in existing sectors.
Segments covered
By Source (Hemp Derived, Marijuana Derived)
By Application (Food and Beverages, Cosmetics and Personal Care, Pharmaceuticals, Others)
By Form (Process Oil, Distillate, Isolate)
Key players
Isodiol
Canopy Growth Corporation
Medical Marijuana Inc
NuLeaf Naturals
CV Sciences
Green Roads
Folium Biosciences
GW Pharmaceuticals
Medterra
Aurora Cannabis
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook